4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001209191-23-049648
Director sold 29,588 shares at an average $75.18 ($2,224,430)
- Director acquired 11,016 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2023-09-15 | Option exercise 10b5-1 | +11,016 | $3.67 | $40,429 | 36,113 | D |
| Coleman Mark Director | 2023-09-15 | Sale 10b5-1 | −11,016 | $75.19 | $828,241 | 25,097 | D |
| Coleman Mark Director | 2023-09-15 | Sale 10b5-1 | −18,572 | $75.18 | $1,396,189 | 403,856 | I |
| Derivatives | |||||||
| Coleman Mark Director | 2023-09-15 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,016 | 0 | D | ||
| Open-market sales · 29,588 sh · avg $75.18 · $2,224,430 | |||||||
Loading xslF345X05/doc4.xml…